Brief: Genmab Says 2025 Revised FY Revenue Outlook 3,500 USD Million To 3,700 USD Million

Genmab A/S

07/08/2025 16:22

Aug 7 (Reuters) - Genmab A/S GMAB.CO:

GENMAB - 2025 REVISED FY OUTLOOK OPERATING PROFIT $1,055 MILLION - $1,405 MILLION

GENMAB - 2025 REVISED FY OUTLOOK REVENUE 3,500 USD MILLION - 3,700 USD MILLION

GENMAB - GENMAB REVENUE INCREASED 19% COMPARED TO FIRST SIX MONTHS OF 2024, TO $1,640 MILLION

GENMAB A/S - OPERATING PROFIT INCREASED TO $548 MILLION IN H1 2025

GENMAB A/S - DARZALEX SALES UP 22% TO $6,776 MILLION IN H1 2025

GENMAB A/S - UPDATES 2025 GUIDANCE DUE TO DARZALEX ROYALTIES

Source text: ID:nNDL9qr2CX

Further company coverage: GMAB.CO

 ((Reuters.Briefs@thomsonreuters.com;))